Home/Filings/4/0001213900-21-012343
4//SEC Filing

Pankovcin Corinne 4

Accession 0001213900-21-012343

CIK 0001726711other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 6:13 AM ET

Size

4.8 KB

Accession

0001213900-21-012343

Insider Transaction Report

Form 4
Period: 2021-02-24
Pankovcin Corinne
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2021-02-24+110,000110,000 total
Footnotes (1)
  • [F1]The restricted common stock shall vest in three (3) successive equal annual installments, beginning on March 31, 2021.

Documents

1 file

Issuer

Aditx Therapeutics, Inc.

CIK 0001726711

Entity typeother

Related Parties

1
  • filerCIK 0001527535

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:13 AM ET
Size
4.8 KB